{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:49:36Z","timestamp":1790243376246,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007792","name":"Society of Critical Care Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jfma.2020.05.028","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T07:58:58Z","timestamp":1591603138000},"page":"S58-S66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"S1","title":["Treatment for Mycobacterium abscessus complex\u2013lung disease"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8707-5966","authenticated-orcid":false,"given":"Ya-Wei","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Len","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Sheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5162-2414","authenticated-orcid":false,"given":"Susan Shin-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2020.05.028_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/CMR.15.4.716-746.2002","article-title":"Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria","volume":"15","author":"Brown-Elliott","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jfma.2020.05.028_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1513\/AnnalsATS.201501-015OI","article-title":"Mycobacterium abscessus. \u201cPleased to meet you, hope you guess my name...\u201d","volume":"12","author":"Griffith","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jfma.2020.05.028_bib3","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/504381","article-title":"Infections due to rapidly growing mycobacteria","volume":"42","author":"De Groote","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib4","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3201\/2109.141634","article-title":"Mycobacterium abscessus complex infections in humans","volume":"21","author":"Lee","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib6","doi-asserted-by":"crossref","first-page":"ofy022","DOI":"10.1093\/ofid\/ofy022","article-title":"Mycobacterium abscessus complex infections: a retrospective cohort study","volume":"5","author":"Sfeir","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/ajrccm\/147.5.1271","article-title":"Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients","volume":"147","author":"Griffith","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib10","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","volume":"72","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.jfma.2020.05.028_bib11","doi-asserted-by":"crossref","first-page":"16300","DOI":"10.1038\/s41598-017-16559-z","article-title":"Epidemiology and predictors of NTM pulmonary infection in Taiwan - a retrospective, five-year multicenter study","volume":"7","author":"Huang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jfma.2020.05.028_bib12","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes","author":"Woods","year":"2011"},{"key":"10.1016\/j.jfma.2020.05.028_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0929-6646(08)60088-1","article-title":"Antimicrobial resistance of rapidly growing mycobacteria in western Taiwan: SMART program 2002","volume":"107","author":"Huang","year":"2008","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2020.05.028_bib14","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1128\/AAC.47.6.1958-1962.2003","article-title":"High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan","volume":"47","author":"Yang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1684-1182(10)60063-1","article-title":"Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing","volume":"43","author":"Huang","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2020.05.028_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2012.10.021","article-title":"Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan","volume":"41","author":"Huang","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jfma.2020.05.028_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1128\/AAC.00861-10","article-title":"Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing","volume":"55","author":"Bastian","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","article-title":"Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance","volume":"186","author":"Choi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib20","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/jac\/dku007","article-title":"Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus","volume":"69","author":"Maurer","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","article-title":"Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns","volume":"54","author":"Kim","year":"2010","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jfma.2020.05.028_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3343\/alm.2014.34.1.31","article-title":"The drug resistance profile of Mycobacterium abscessus group strains from Korea","volume":"34","author":"Lee","year":"2014","journal-title":"Ann Lab Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib23","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3389\/fmicb.2019.01977","article-title":"Clinical efficacy and adverse effects of antibiotics used to treat Mycobacterium abscessus pulmonary disease","volume":"10","author":"Chen","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib25","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1086\/515328","article-title":"A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae","volume":"177","author":"Prammananan","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib26","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/jac\/dkr209","article-title":"Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus","volume":"66","author":"Nessar","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005660","article-title":"Non mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium abscessus","volume":"4","author":"Ripoll","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2020.05.028_bib28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkr578","article-title":"Mycobacterium abscessus: a new antibiotic nightmare","volume":"67","author":"Nessar","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib29","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1093\/jac\/dku550","article-title":"Aminoglycoside-modifying enzymes determine the innate susceptibility to aminoglycoside antibiotics in rapidly growing mycobacteria","volume":"70","author":"Maurer","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12879-017-2298-8","article-title":"Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan","volume":"17","author":"Hatakeyama","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib31","doi-asserted-by":"crossref","first-page":"419392","DOI":"10.1155\/2015\/419392","article-title":"Drug susceptibility testing of 31 antimicrobial agents on rapidly growing mycobacteria isolates from China","volume":"2015","author":"Pang","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.jfma.2020.05.028_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3346\/jkms.2008.23.1.49","article-title":"In\u00a0vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea","volume":"23","author":"Park","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jfma.2020.05.028_bib33","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/jac\/dkw130","article-title":"Standardized interpretation of antibiotic susceptibility testing and resistance genotyping for Mycobacterium abscessus with regard to subspecies and erm41 sequevar","volume":"71","author":"Mougari","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib34","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the in\u00a0vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208053","article-title":"Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand","volume":"13","author":"Ananta","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.jfma.2020.05.028_bib36","doi-asserted-by":"crossref","first-page":"O297","DOI":"10.1111\/1469-0691.12405","article-title":"In\u00a0vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex","volume":"20","author":"Lavollay","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jfma.2020.05.028_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1128\/JCM.02260-12","article-title":"Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom","volume":"51","author":"Broda","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib38","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1911.130737","article-title":"Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010","volume":"19","author":"Marras","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib39","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/1471-2458-10-612","article-title":"Increasing reports of non-tuberculous mycobacteria in England, wales and Northern Ireland, 1995\u20132006","volume":"10","author":"Moore","year":"2010","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.jfma.2020.05.028_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4046\/trd.2013.75.5.199","article-title":"Increasing recovery of nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea","volume":"75","author":"Koh","year":"2013","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.jfma.2020.05.028_bib41","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib42","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3201\/eid1602.090675","article-title":"Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000-2008","volume":"16","author":"Lai","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib43","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jmii.2014.08.005","article-title":"Risk factors for microbiologic failure among Taiwanese adults with Mycobacterium abscessus complex pulmonary disease","volume":"48","author":"Tung","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jfma.2020.05.028_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib45","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib46","first-page":"499","article-title":"Nontuberculous mycobacterial lung disease in southern Taiwan","volume":"32","author":"Wang","year":"2009","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.jfma.2020.05.028_bib47","doi-asserted-by":"crossref","first-page":"e2234","DOI":"10.1371\/journal.pntd.0002234","article-title":"Emergence of clinically relevant non-tuberculous mycobacterial infections in Saudi Arabia","volume":"7","author":"Varghese","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-019-3909-3","article-title":"Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012\u20132016","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib49","series-title":"Nontuberculous mycobacteria (NTM) guidelines for health professionals in the northern territory","author":"Control CfD","year":"2014"},{"key":"10.1016\/j.jfma.2020.05.028_bib50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1164\/rccm.200905-0704OC","article-title":"Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients","volume":"180","author":"Jeon","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib52","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1148\/radiol.12111374","article-title":"Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy","volume":"263","author":"Kim","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jfma.2020.05.028_bib53","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/JCM.01175-12","article-title":"Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases","volume":"50","author":"Harada","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciw724","article-title":"Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease","volume":"64","author":"Koh","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijantimicag.2013.04.029","article-title":"Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents","volume":"42","author":"Yoshida","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jfma.2020.05.028_bib56","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/JCM.02950-14","article-title":"Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs","volume":"53","author":"Brown-Elliott","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib57","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1128\/JCM.01714-15","article-title":"New real-time PCR assays for detection of inducible and acquired clarithromycin resistance in the Mycobacterium abscessus group","volume":"53","author":"Shallom","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01206-17","article-title":"Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence","volume":"61","author":"Pasipanodya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib59","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01991-2018","article-title":"M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jfma.2020.05.028_bib60","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/AAC.01505-12","article-title":"In\u00a0vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease","volume":"56","author":"van Ingen","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib61","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijantimicag.2009.12.008","article-title":"High efficacy of\u00a0clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria","volume":"35","author":"Shen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jfma.2020.05.028_bib62","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2017.04.175","article-title":"Safety and effectiveness of clofazimine for primary and refractory nontuberculous mycobacterial infection","volume":"152","author":"Martiniano","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jfma.2020.05.028_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02052-16","article-title":"Clofazimine-containing regimen for the treatment of Mycobacterium abscessus lung disease","volume":"61","author":"Yang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib64","article-title":"Clinical outcomes of clofazimine use for rapidly growing mycobacterial infections","volume":"6","author":"Carey","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib65","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12879-017-2665-5","article-title":"The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases","volume":"17","author":"Yagi","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jfma.2020.05.028_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib68","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3389\/fmicb.2018.00915","article-title":"Amikacin liposome inhalation suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages","volume":"9","author":"Zhang","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib69","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jfma.2020.05.028_bib70","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1086\/606050","article-title":"Clinical management of rapidly growing mycobacterial cutaneous infections in patients after mesotherapy","volume":"49","author":"Regnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jfma.2020.05.028_bib71","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/AAC.03112-15","article-title":"Tigecycline is highly efficacious against Mycobacterium abscessus pulmonary disease","volume":"60","author":"Ferro","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib72","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","article-title":"Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections","volume":"69","author":"Wallace","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib73","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/AAC.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"45","author":"Wallace","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jfma.2020.05.028_bib74","first-page":"411","article-title":"Activities of Linezolid against nontuberculous mycobacteria","volume":"30","author":"Cavusoglu","year":"2007","journal-title":"New Microbiol"},{"key":"10.1016\/j.jfma.2020.05.028_bib75","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1183\/09031936.00169114","article-title":"The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease","volume":"45","author":"Winthrop","year":"2015","journal-title":"Eur Respir J"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620302187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664620302187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:41:50Z","timestamp":1760539310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664620302187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":75,"alternative-id":["S0929664620302187"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2020.05.028","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment for Mycobacterium abscessus complex\u2013lung disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2020.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}